{"title":"广泛性脓疱性银屑病的Secukinumab与阿维a相关","authors":"Gisondi Paolo, Pizzolato Miriam, Girolomoni Giampiero","doi":"10.33552/ACCS.2018.01.000508","DOIUrl":null,"url":null,"abstract":"Generalized pustular psoriasis (GPP) is a severe inflammatory skin disease characterized by the presence of sterile pustules covering almost the entire body and it may be associated with systemic symptoms. There is an increasing need for specific treatment options for GPP, because this skin disorder is frequently resistant to therapies indicated for chronic plaque psoriasis. Preliminary data suggest that interleukin (IL)-17 could be a promising therapeutic target for GPP.","PeriodicalId":151968,"journal":{"name":"Archives of Clinical Case Studies","volume":" 9","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Secukinumab Associated with Acitretin in Generalized Pustular Psoriasis\",\"authors\":\"Gisondi Paolo, Pizzolato Miriam, Girolomoni Giampiero\",\"doi\":\"10.33552/ACCS.2018.01.000508\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Generalized pustular psoriasis (GPP) is a severe inflammatory skin disease characterized by the presence of sterile pustules covering almost the entire body and it may be associated with systemic symptoms. There is an increasing need for specific treatment options for GPP, because this skin disorder is frequently resistant to therapies indicated for chronic plaque psoriasis. Preliminary data suggest that interleukin (IL)-17 could be a promising therapeutic target for GPP.\",\"PeriodicalId\":151968,\"journal\":{\"name\":\"Archives of Clinical Case Studies\",\"volume\":\" 9\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-12-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Clinical Case Studies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33552/ACCS.2018.01.000508\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Clinical Case Studies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33552/ACCS.2018.01.000508","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Secukinumab Associated with Acitretin in Generalized Pustular Psoriasis
Generalized pustular psoriasis (GPP) is a severe inflammatory skin disease characterized by the presence of sterile pustules covering almost the entire body and it may be associated with systemic symptoms. There is an increasing need for specific treatment options for GPP, because this skin disorder is frequently resistant to therapies indicated for chronic plaque psoriasis. Preliminary data suggest that interleukin (IL)-17 could be a promising therapeutic target for GPP.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
